Publication | Closed Access

[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial

UrologyOncologyGenitourinary CancerMedicineClinical TrialsPharmacotherapyCancer TreatmentProstatic DiseasePharmacologyMolecular Oncology